Cellvie is a seed startup based in Switzerland. 1 investor tracked.
Cellvie is a company founded in 2018 headquartered in Switzerland. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
A biotechnology company pioneering Therapeutic Mitochondria Transplantation (TMT) as a new treatment modality for ischemia-reperfusion injuries (IRI), which occur when blood flow is restored to tissues after a period of oxygen deprivation.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.